NCT00605800

Brief Summary

The results of this study may or may not establish useful baseline data, which will help us understand how bone marrow derived adult liver stem cells behave in normal healthy adults/volunteers (the control group), and in patients undergoing liver surgery. The bone marrow is located within your bones and is the organ which is responsible to produce blood cells and stem cells. Bone marrow derived adult liver stem cells are normal cells in your bone marrow. These liver stem cells have the capacity to regenerate or in other words to rebuild the liver after liver surgery, a process called liver regeneration. These cells are very important for the liver to regrow its tissue after liver surgery. These cells are thought to be activated in times of need by the liver. Situations like liver surgery are one of these occasions when the liver will need the "extra help" from these stem cells. The results of this study will establish the baseline data necessary for the understanding of how to harness the ability of these stem cells in times of liver surgery. Improvements in the ability of the liver to regrow after surgery is thought to decrease complications related to liver surgery. Harnessing this unique ability of stem cells may be utilized in the future to enhance the regrowing process of liver tissue after liver surgery, called liver regeneration.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2006

Typical duration for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2006

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

January 17, 2008

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 31, 2008

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2009

Completed
Last Updated

March 19, 2009

Status Verified

March 1, 2009

Enrollment Period

3 years

First QC Date

January 17, 2008

Last Update Submit

March 18, 2009

Conditions

Keywords

Liver resection

Outcome Measures

Primary Outcomes (1)

  • To determine qualitatively and quantitatively whether bone marrow derived liver associated stem cells are mobilized from the bone marrow in patients undergoing major liver resections (3 or more liver segments).

    conclusion of study

Secondary Outcomes (1)

  • To determine whether a difference exist in the baseline levels of bone marrow derived liver associated stem cells between normal healthy subjects/ volunteers and cancer patients prior to liver surgery.

    conclusion of study

Study Arms (2)

1

normal healthy volunteers

Other: blood drawn

2

Patients undergoing major liver resections

Other: blood drawn

Interventions

Baseline levels of bone marrow derived liver stem cells from normal healthy volunteers, which will be drawn once Two 5ml blue tubes).

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

MSKCC clinics Normal healthy volunteers

You may qualify if:

  • Adults (≥ or equal to 18 years old).
  • Patients scheduled for resection of 3 or more liver segments for any indication, with or without other planned procedures.
  • Normal healthy volunteers (control).

You may not qualify if:

  • Chemotherapy or GCSF treatment in the preceding 4 weeks.
  • CHILD'S classification B or above.
  • Presence of active infection.
  • History of lymphoma or leukemia.
  • Normal healthy volunteers who underwent chemotherapy treatment at any stage of their life will be excluded.
  • Normal healthy volunteers who are under any active treatment for any active illness will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Blood

MeSH Terms

Conditions

Liver Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesLiver Diseases

Study Officials

  • Ronald DeMatteo, MD

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 17, 2008

First Posted

January 31, 2008

Study Start

March 1, 2006

Primary Completion

March 1, 2009

Study Completion

March 1, 2009

Last Updated

March 19, 2009

Record last verified: 2009-03